Custom cancer vaccine fights deadly eye tumor return
Disease control
Completed
This study tested whether a personalized vaccine could prevent cancer from returning in patients with a high-risk form of eye melanoma (uveal melanoma) after their tumor was surgically removed. 200 patients who had their tumor removed but were at high risk for the cancer spreadin…
Phase: PHASE3 • Sponsor: University Hospital Erlangen • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC